Wellcome Sanger Institute

The Wellcome Sanger Institute is one of the foremost centres of genomics research and innovation in the world, carrying out leading-edge scientific research that uses genome sequences to understand the biology of humans and pathogens (organisms that cause diseases, such as bacteria and viruses).

The Institute leads ambitious collaborations across the globe that create the necessary networks of experts and facilities to support highly excellent research and transformative healthcare innovations, worldwide.

The major theme of the Institute’s science is genome variation – naturally occurring and engineered. This field of study provides us with insights into the evolution of humans and pathogens; human development and ageing; the consequences of genome variation at levels from the single cell to the whole organism; and interactions between pathogens and hosts. The applications of this work are mainly in rare and common genetic diseases, cancer and infection.

We carry out studies that are of design and scale that cannot be conducted in most biomedical research institutes; our science is on an industrial scale, generating and analyzing vast quantities of data.

The Institute’s many successes are founded on the expertise and knowledge of the people who work there. Faculty members conceive and deliver the Institute’s science and innovation activity, driving organisational aspirations with their vision, imagination, and intellectual vigour.

Sharing discoveries and techniques with the next generation of genomics scientists and researchers, worldwide, is a vital part of the Institute’s work.

Wellcome Sanger Institute News

Loading...

>1,500

employees including PhDs and visiting workers

44

faculty members

82

PhD students

60

countries. Our staff are drawn from an international talent pool

Sanger Institute's current job vacancies

Loading...

>3,750

billion letters of DNA sequenced each day by the Wellcome Sanger Institute

42

2,414

papers published in the period (2010-2014)

12%

of all Sanger Institute papers produced (2010-2014) are in the top 1% of world's most cited papers

EMBL-EBI

EMBL-EBI was founded in 1994 as a European Treaty organization. Its co-location with the Wellcome Sanger Institute offers vital synergies. EMBL-EBI provides freely available data from life sciences research and maintains the world’s most comprehensive range of open access molecular databases, used by millions of researchers in academia and industry, globally.